13F
← All fund report cards

Invesco Ltd.

13F equity value
$653.3B
Positions
3,732
Top 10 concentration
18.6%
Quarters / total new picks
32 / 1,365
13F equity value over time
$0M$327B$653B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +2.1% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 50.0% of quarters (excess t = 0.09, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
+0.2%
t-stat
0.09
Quarterly win rate
50%
Annualized excess
-4.3%
$1 → follow vs universe
$1.52 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.09420180630: follow 1.00520180930: follow 1.08720181231: follow 1.16920190331: follow 1.12520190630: follow 1.15120190930: follow 1.28820191231: follow 1.09520200331: follow 1.33920200630: follow 1.35920200930: follow 1.85220201231: follow 1.56220210331: follow 1.64920210630: follow 1.75820210930: follow 1.32820211231: follow 1.00520220331: follow 1.08420220630: follow 0.96720220930: follow 1.06720221231: follow 0.98920230331: follow 1.01820230630: follow 0.90920230930: follow 0.99020231231: follow 1.01120240331: follow 1.04020240630: follow 1.08720240930: follow 1.20420241231: follow 1.06620250331: follow 1.16220250630: follow 1.20520250930: follow 1.44120251231: follow 1.519 0.84 1.54 2.25 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 3732 · 2026 Q1

Ticker Value Weight QoQ
NVDA $24.9B
3.8%
HOLD
AAPL $18.5B
2.8%
HOLD
MSFT $15.7B
2.4%
TRIM
GOOGL $13.2B
2.0%
HOLD
AMZN $11.9B
1.8%
TRIM
AVGO $10.3B
1.6%
TRIM
META $8.9B
1.4%
TRIM
GOOG $6.6B
1.0%
ADD
TSLA $6.3B
1.0%
HOLD
WMT $5.4B
0.8%
ADD
LRCX $5.2B
0.8%
ADD
CSCO $4.4B
0.7%
TRIM
COST $4.3B
0.7%
HOLD
NFLX $4.1B
0.6%
HOLD
MU $4.1B
0.6%
ADD
JNJ $3.7B
0.6%
ADD
JPM $3.6B
0.6%
TRIM
TXN $3.5B
0.5%
HOLD
AMAT $3.3B
0.5%
ADD
AMD $3.3B
0.5%
ADD

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.